COVID19
Seegene to Launch New COVID-19 PCR Test for Mass Testing
Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today the upcoming launch of the Allplex™ SARS-CoV...
January 20, 2022 | News
Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
January 20, 2022 | News
The Philippines Has Approved ReCOV For Phase II/III Clinical Trial
Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing ...
January 18, 2022 | News
Seegene to export COVID-19 test that detects COVID-19 and Omicron
Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today that it has delivered over five million COVID...
January 18, 2022 | News
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant
LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 ...
January 17, 2022 | News
Singapore biotech firm JN Medsys develops a PCR test kit
Singapore-based biotech firm, JN Medsys announces that it has developed a new PCR kit that detects for SARS-CoV-2 and identifies if the Omicron variant is ...
January 13, 2022 | News
LumiraDx receives CE marking after successful CRP test
Quantitative results within 4 minutes of sampling facilitate rapid clinical decision-making at the point of care (POC) LumiraDx (Nasdaq: LMDX),...
January 12, 2022 | News
Singapore scientists awarded Wellcome Leap R3 contract to develop mRNA technology
A team of researchers from A*STAR’s Genome Institute of Singapore (GIS) and Institute of Bioengineering and Bioimaging (IBB), together with the Natio...
January 07, 2022 | News
Aurobindo rolls out molnaflu, oral covid drug for adult patients In India
Molnupiravir was earlier approved under Emergency Use Authorisation from CDSCO, India. This is the first oral antiviral approved by India, the UK agency an...
January 06, 2022 | News
B. subtilis Spores, Biotechnology Breakthrough by DreamTec
Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) ha...
January 05, 2022 | News
Celltrion plans to provide dual treatment options for COVID-19 in South Korea
CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...
January 04, 2022 | News
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002
A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...
January 04, 2022 | News
Ascletis Expands Ritonavir Oral Tablet Production
Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...
January 03, 2022 | News
Siemens Healthineers Announces FDA EUA For CLINITEST® Rapid COVID-19 Antigen Self-Test
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure. Through nationwide retail d...
December 30, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
